100 related articles for article (PubMed ID: 7531274)
1. Nephrotoxicity of immunosuppressive drugs.
Bennett WM; Burdmann E; Andoh T; Elzinga L; Franceschini N
Miner Electrolyte Metab; 1994; 20(4):214-20. PubMed ID: 7531274
[TBL] [Abstract][Full Text] [Related]
2. Nephrotoxicity of immunosuppressive drugs.
Bennett WM; Burdmann EA; Andoh TF; Houghton DC; Lindsley J; Elzinga LW
Nephrol Dial Transplant; 1994; 9 Suppl 4():141-5. PubMed ID: 7528363
[TBL] [Abstract][Full Text] [Related]
3. The nephrotoxicity of immunosuppressive drugs.
Bennett WM
Clin Nephrol; 1995 Jan; 43 Suppl 1():S3-7. PubMed ID: 7540121
[TBL] [Abstract][Full Text] [Related]
4. Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations.
Andoh TF; Burdmann EA; Bennett WM
Semin Nephrol; 1997 Jan; 17(1):34-45. PubMed ID: 9000548
[TBL] [Abstract][Full Text] [Related]
5. Nephrotoxicity associated with cyclosporine and FK506.
Klintmalm GB; Gonwa TA
Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):11-9. PubMed ID: 9346596
[TBL] [Abstract][Full Text] [Related]
6. The role of calcium-channel antagonists in solid organ transplantation.
Huntress JD; Papadakos PJ
New Horiz; 1996 Feb; 4(1):129-33. PubMed ID: 8689268
[TBL] [Abstract][Full Text] [Related]
7. Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation.
Morales JM; Andres A; Rengel M; Rodicio JL
Nephrol Dial Transplant; 2001; 16 Suppl 1():121-4. PubMed ID: 11369839
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: are the morphologic characteristics of FK506 and CyA nephrotoxicity similar?
Morozumi K; Sugito K; Oda A; Takeuchi O; Fukuda M; Usami T; Oikawa T; Fujinami T; Koyama K; Takeda A; Yoshida A; Haba T; Tominaga Y; Uchida K; Yokoyama I; Takagi H
Transplant Proc; 1996 Apr; 28(2):1076-8. PubMed ID: 8623232
[No Abstract] [Full Text] [Related]
9. [Acute peripheral demyelinating polyneuropathy and acute renal failure after administration of FK506].
Laham G; Vilches A; Jost L; Jost L; Nogués M
Medicina (B Aires); 2001; 61(4):445-6. PubMed ID: 11563175
[TBL] [Abstract][Full Text] [Related]
10. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects.
Asante-Korang A; Boyle GJ; Webber SA; Miller SA; Fricker FJ
J Heart Lung Transplant; 1996 Apr; 15(4):415-22. PubMed ID: 8732602
[TBL] [Abstract][Full Text] [Related]
11. Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies.
Fervenza FC; Fitzpatrick PM; Mertz J; Erickson SB; Liggett S; Popham S; Wochos DN; Synhavsky A; Hippler S; Larson TS; Bagniewski SM; Velosa JA;
Nephrol Dial Transplant; 2004 May; 19(5):1288-92. PubMed ID: 15102967
[TBL] [Abstract][Full Text] [Related]
12. ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients.
Gallon L; Akalin E; Lynch P; Rothberg L; Parker M; Schiano T; Abecassis M; Murphy B
Transplantation; 2006 Feb; 81(3):463-8. PubMed ID: 16477235
[TBL] [Abstract][Full Text] [Related]
13. The role of immunosuppressive drugs in aggravating renal ischemia and reperfusion injury.
Gonçalves GM; Cenedeze MA; Feitoza CQ; de Paula CB; Marques GD; Pinheiro HS; de Paula Antunes Teixeira V; Antônia dos Reis M; Pacheco-Silva A; Câmara NO
Transplant Proc; 2007 Mar; 39(2):417-20. PubMed ID: 17362745
[TBL] [Abstract][Full Text] [Related]
14. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ
Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
[TBL] [Abstract][Full Text] [Related]
15. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
16. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?
Chapman JR; Nankivell BJ
Nephrol Dial Transplant; 2006 Aug; 21(8):2060-3. PubMed ID: 16728428
[No Abstract] [Full Text] [Related]
17. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
18. Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin.
Ryffel B; Weber E; Mihatsch MJ
Exp Nephrol; 1994; 2(6):324-33. PubMed ID: 7532090
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus conversion for renal preservation in liver transplantation: not so fast.
Jensen GS; Wiseman A; Trotter JF
Liver Transpl; 2008 May; 14(5):601-3. PubMed ID: 18433068
[No Abstract] [Full Text] [Related]
20. Beneficial metabolic impact of the novel immunosuppressant rapamycin in chronic canine islet autograft recipients.
Kneteman NM; Lakey JR; Wagner T; Finegood D
Transplant Proc; 1995 Dec; 27(6):3213. PubMed ID: 8539919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
